Sansure Biotech, Inc., based in China, operates in the healthcare industry with a risk rating score of 28.8, classifying it as a medium-risk company. Specializing in the production and sales of diagnostic reagents and instruments, Sansure Biotech offers a wide range of medical products including Class I, II, and III medical devices, general instruments, meters, raw materials, laboratory equipment, and accessories. The company's focus on ESG factors sets it apart in the market, making it a reliable choice for sustainable healthcare solutions.